Results 21 to 30 of about 9,528 (197)

Transfemoral Transcatheter Tricuspid Valve Replacement

JACC: Cardiovascular Interventions, 2020
A 75-year-old man presented with New York Heart Association functional class III dyspnea, edema, and fatigue. His history included coronary bypass graft surgery and atrial fibrillation. Echocardiography demonstrated torrential tricuspid regurgitation with leaflet tethering and a 15-mm coaptation ...
Neil P Fam, Djeven P Deva, Mark D Peterson   +2 more
exaly   +3 more sources

Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation

The Thoracic & Cardiovascular Surgeon Reports, 2017
Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position
Daniel Reichart, Niklas Schofer, Florian Deuschl, Andreas Schaefer, Stefan Blankenberg, Hermann Reichenspurner, Ulrich Schaefer, Lenard Conradi   +7 more
doaj   +2 more sources

Transcatheter Tricuspid Valve Replacement: Principles and Design [PDF]

Frontiers in Cardiovascular Medicine, 2018
Tricuspid regurgitation (TR) may affect as much as 65–85% of the population with the prevalence of moderate-to-severe TR in the United States reported at greater than 1.6 million.
Ozan M. Demir, Ozan M. Demir, Damiano Regazzoli, Antonio Mangieri, Marco B. Ancona, Satoru Mitomo, Giora Weisz, Antonio Colombo, Azeem Latib, Azeem Latib   +9 more
doaj   +3 more sources

Transcatheter Tricuspid Valve Intervention: Current Perspective [PDF]

US Cardiology Review, 2021
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects.
Trevor J Simard, Mackram F Eleid
doaj   +2 more sources

First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System

JACC: Case Reports, 2023
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging.
Lars Sondergaard, MD, DMSc, Jacob Eifer Møller, MD, PhD, Ole De Backer, MD, PhD, Peter Hasse Møller-Sørensen, MD, PhD, Yanping Cheng, MD, Kasper Rossing, MD, DMSc, Morten Smerup, MD, Arshad Quadri, MD   +7 more
doaj   +3 more sources

Transcatheter tricuspid valve interventions: Current status and future perspectives [PDF]

Frontiers in Cardiovascular Medicine, 2022
The development of transcatheter therapies to treat valvular heart diseases has changed the rules of the game, particularly in the case of aortic stenosis and mitral regurgitation.
Alberto Alperi, Alberto Alperi, Marcel Almendárez, Marcel Almendárez, Rut Álvarez, Rut Álvarez, Cesar Moris, Cesar Moris, Cesar Moris, Victor Leon, Victor Leon, Iria Silva, Iria Silva, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Isaac Pascual, Isaac Pascual, Isaac Pascual, Pablo Avanzas, Pablo Avanzas, Pablo Avanzas   +21 more
doaj   +2 more sources

Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR).
Wang Wei, Li Ning, Li Ning, Ning Xiaoping, Xu Zhiyun, Li Bailing, Cai Chengliang, Yang Fan, Zhou Guangwei, Bai Yifan, Han Lin, Qiao Fan, Lu Fanglin   +12 more
doaj   +3 more sources

Transcatheter Tricuspid Valve Replacement Beyond Boundaries [PDF]

JACC: Case Reports
Transcatheter tricuspid valve replacement (TTVR) is now an available option to treat patients with severe symptomatic tricuspid regurgitation. Because of the early experience in this field, many challenges remain to be addressed. In this case series, we present 3 different situations that underline the difficulties in the clinical management of these ...
Le Ruz, Robin, George, Isaac, Agarwal, Vratika, Nazif, Tamim, Lebehn, Mark, Pinheiro Rezende, Carolina, Vahl, Torsten, Leon, Martin, Hahn, Rebecca, Kodali, Susheel   +9 more
openaire   +4 more sources

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano, Sabrina Trippoli, Andrea Messori, Vincenzo Calderone, Eugenia Piragine   +4 more
doaj   +2 more sources

Transcatheter Tricuspid Valve Replacement With a Dedicated Device in a Patient With 2 Endocardial Leads

JACC: Case Reports, 2023
A 79-year-old woman with a history of dilated cardiomyopathy who required a permanent peacemaker, recently upgraded to implantable cardioverter-defibrillator cardiac resynchronization therapy, was admitted for right heart failure.
Rodrigo Estevez-Loureiro, MD, PhD, Manuel Barreiro-Pérez, MD, PhD, Miguel Piñon, MD, PhD, Rocío González, MD, PhD, David Dobarro, MD, PhD, Thomas Modine, MD, PhD, Anson Cheung, MD, PhD, Jose A. Baz-Alonso, MD, Berenice Caneiro-Queija, MD, Andrés Íñiguez-Romo, MD, PhD   +9 more
doaj   +2 more sources